R&D burn is accelerating, but your runway model doesn't account for grant timing or milestone delays.
Your IP is your most valuable asset, yet your financials don't reflect its true development cost.
Grant reporting is consuming founder time, and one error can freeze funding.
Your investor updates show R&D milestones, not a financial model they can stress-test.
Your finance setup was built for a 5-person research team. It won't survive commercialization.
